OncoMed Pharmaceuticals Inc: key financial figures for fiscal year 2018 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2018)
- $44.4M
- Net Income/Loss (FY2018)
- -$8.1M
- Total Assets (FY2018)
- $65.1M
- Total Equity (FY2018)
- $48.2M
- Cash Flows from Operating Activities (FY2018)
- -$44.9M
Source: OncoMed Pharmaceuticals Inc 10-K filing (FY2018). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
